| Medical and Health Sciences | Lifetime | 527 | US 285 | 99.98 |
| Surgery | Lifetime | 133 | US 70 | 99.89 |
| Epidemiology | Lifetime | 147 | US 79 | 99.81 |
| Hepatology | Lifetime | 40 | US 18 | 99.74 |
| Oncology | Lifetime | 348 | US 198 | 99.41 |
| Pharmacology | Lifetime | 201 | US 91 | 98.25 |
| Cell Biology | Lifetime | 835 | US 456 | 94.53 |
| Surgery | 2021-2025 | 444 | US 173 | 96.52 |
| Hepatology | 2021-2025 | 245 | US 61 | 85.52 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 1 | US 1 | 99.99 |
| Gallbladder and Bile Duct Disorders | Lifetime | 5 | US 5 | 99.94 |
| Liver Disease Diagnosis and Treatment | Lifetime | 18 | US 8 | 99.94 |
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 6 | US 5 | 99.86 |
| Cell death mechanisms and regulation | Lifetime | 16 | US 8 | 99.79 |
| Drug-Induced Hepatotoxicity and Protection | Lifetime | 18 | US 10 | 99.75 |
| Liver Diseases and Immunity | Lifetime | 12 | US 9 | 99.83 |
| Liver physiology and pathology | Lifetime | 17 | US 7 | 99.72 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 64 | US 30 | 99.67 |
| Drug Transport and Resistance Mechanisms | Lifetime | 70 | US 33 | 99.54 |
| Hepatitis B Virus Studies | Lifetime | 88 | US 32 | 99.70 |
| Cancer Mechanisms and Therapy | Lifetime | 32 | US 20 | 99.38 |
| Viral-associated cancers and disorders | Lifetime | 90 | US 47 | 99.31 |
| Endoplasmic Reticulum Stress and Disease | Lifetime | 90 | US 52 | 99.14 |
| Phagocytosis and Immune Regulation | Lifetime | 41 | US 15 | 98.95 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 284 | US 142 | 99.17 |
| MicroRNA in disease regulation | Lifetime | 565 | US 161 | 98.18 |
| Liver Disease and Transplantation | Lifetime | 541 | US 187 | 98.60 |
| Organ Transplantation Techniques and Outcomes | Lifetime | 846 | US 366 | 97.72 |
| Transplantation: Methods and Outcomes | Lifetime | 901 | US 499 | 96.09 |
| Autophagy in Disease and Therapy | Lifetime | 916 | US 289 | 95.01 |
| Calpain Protease Function and Regulation | Lifetime | 529 | US 203 | 82.36 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 70 | US 20 | 98.19 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 281 | US 55 | 95.12 |
| Pediatric Hepatobiliary Diseases and Treatments | 2021-2025 | 500 | US 108 | 86.61 |
| Liver Diseases and Immunity | 2021-2025 | 420 | US 106 | 86.64 |
| Liver physiology and pathology | 2021-2025 | 500 | US 77 | 76.61 |
| Viral-associated cancers and disorders | 2021-2025 | 941 | US 336 | 77.42 |
